Vitamin A in health care: Suppression of growth and induction of differentiation in cancer cells by vitamin A and its derivatives and their mechanisms of action

Pharmacol Ther. 2022 Feb:230:107942. doi: 10.1016/j.pharmthera.2021.107942. Epub 2021 Jun 24.

Abstract

Vitamin A is an important micro-essential nutrient, whose primary dietary source is retinyl esters. In addition, β-carotene (pro-vitamin A) is a precursor of vitamin A contained in green and yellow vegetables that is converted to retinol in the body after ingestion. Retinol is oxidized to produce visual retinal, which is further oxidized to retinoic acid (RA), which is used as a therapeutic agent for patients with promyelocytic leukemia. Thus, the effects of retinal and RA are well known. In this paper, we will introduce (1) vitamin A circulation in the body, (2) the actions and mechanisms of retinal and RA, (3) retinoylation: another RA mechanism not depending on RA receptors, (4) the relationship between cancer and actions of retinol or β-carotene, whose roles in vivo are still unknown, and (5) anti-cancer actions of vitamin A derivatives derived from fenretinide (4-HPR). We propose that vitamin A nutritional management is effective in the prevention of cancer.

Keywords: Cancer; HL60 differentiation; Retinoic acid; Retinol; Retinoylation; Vitamin A.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cell Differentiation
  • Delivery of Health Care
  • Humans
  • Neoplasms* / drug therapy
  • Receptors, Retinoic Acid
  • Tretinoin / pharmacology
  • Vitamin A* / pharmacology

Substances

  • Receptors, Retinoic Acid
  • Vitamin A
  • Tretinoin